Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3300)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$506.76
Total Value
$141.89K
Shares Held After
324,723
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$505.94
Total Value
$303.56K
Shares Held After
325,003
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
702
Price
$505.03
Total Value
$354.53K
Shares Held After
325,603
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
578
Price
$503.76
Total Value
$291.17K
Shares Held After
326,305
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,536
Price
$502.80
Total Value
$772.30K
Shares Held After
326,883
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,244
Price
$501.88
Total Value
$1.13M
Shares Held After
328,419
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,372
Price
$500.58
Total Value
$686.80K
Shares Held After
330,663
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,788
Price
$499.75
Total Value
$893.55K
Shares Held After
332,035
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$498.44
Total Value
$59.81K
Shares Held After
333,823
% of Holdings
0.0%
Aurinia Pharmaceuticals Inc. (AUPH)
Robertson Stephen P. — Chief Legal Officer
Shares
11,939
Price
$15.95
Total Value
$190.43K
Shares Held After
588,848
% of Holdings
2.0%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
5,000
Price
$2.76
Total Value
$13.80K
Shares Held After
662,000
% of Holdings
0.8%
RELMADA THERAPEUTICS, INC. (RLMD)
TRAVERSA SERGIO — Director
Shares
100,000
Price
$4.10
Total Value
$410.00K
Shares Held After
1,500,000
% of Holdings
6.7%
RELMADA THERAPEUTICS, INC. (RLMD)
Shenouda Maged — Chief Financial Officer
Shares
79,800
Price
$4.25
Total Value
$339.15K
Shares Held After
1,000,000
% of Holdings
8.0%
Protagonist Therapeutics, Inc (PTGX)
PATEL DINESH V PH D — Director
Shares
7,278
Price
$144.10
Total Value
$1.05M
Shares Held After
522,968
% of Holdings
1.4%
Lyell Immunopharma, Inc. (LYEL)
Shook David — Chief Medical Officer
Shares
500
Price
$12.70
Total Value
$6.35K
Shares Held After
20,423
% of Holdings
2.4%
Ocugen, Inc. (OCGN)
Musunuri Shankar — Director
Shares
57,264
Price
$1.12
Total Value
$64.14K
Shares Held After
1,088,035
% of Holdings
5.0%
Ocugen, Inc. (OCGN)
Musunuri Shankar — Director
Shares
468,727
Price
$1.12
Total Value
$524.97K
Shares Held After
4,487,197
% of Holdings
9.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
100
Price
$108.67
Total Value
$10.87K
Shares Held After
767,780
% of Holdings
0.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
6,596
Price
$107.82
Total Value
$711.19K
Shares Held After
767,880
% of Holdings
0.9%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
13,304
Price
$107.22
Total Value
$1.43M
Shares Held After
774,476
% of Holdings
1.7%
Metagenomi Therapeutics, Inc. (MGX)
Reid Laurence — Director
Shares
117
Price
$1.18
Total Value
$138.06
Shares Held After
20,000
% of Holdings
0.6%
Metagenomi Therapeutics, Inc. (MGX)
Reid Laurence — Director
Shares
19,883
Price
$1.17
Total Value
$23.26K
Shares Held After
19,883
% of Holdings
100.0%
AN2 Therapeutics, Inc. (ANTX)
Readnour Robin Shane — Director
Shares
585
Price
$6.02
Total Value
$3.52K
Shares Held After
624,765
% of Holdings
0.1%
AN2 Therapeutics, Inc. (ANTX)
Readnour Robin Shane — Director
Shares
523
Price
$6.02
Total Value
$3.15K
Shares Held After
557,467
% of Holdings
0.1%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
572
Price
$68.67
Total Value
$39.28K
Shares Held After
1,326,594
% of Holdings
0.0%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
9,428
Price
$67.79
Total Value
$639.12K
Shares Held After
1,327,166
% of Holdings
0.7%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
160
Price
$542.55
Total Value
$86.81K
Shares Held After
202,967
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
362
Price
$541.65
Total Value
$196.08K
Shares Held After
203,127
% of Holdings
0.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
505
Price
$540.19
Total Value
$272.80K
Shares Held After
203,489
% of Holdings
0.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
215
Price
$539.03
Total Value
$115.89K
Shares Held After
203,994
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
520
Price
$538.30
Total Value
$279.91K
Shares Held After
204,209
% of Holdings
0.3%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
640
Price
$537.17
Total Value
$343.79K
Shares Held After
204,729
% of Holdings
0.3%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
1,040
Price
$536.11
Total Value
$557.56K
Shares Held After
205,369
% of Holdings
0.5%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
644
Price
$535.27
Total Value
$344.72K
Shares Held After
206,409
% of Holdings
0.3%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
396
Price
$534.20
Total Value
$211.54K
Shares Held After
207,053
% of Holdings
0.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
512
Price
$533.09
Total Value
$272.94K
Shares Held After
207,449
% of Holdings
0.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
368
Price
$531.99
Total Value
$195.77K
Shares Held After
207,961
% of Holdings
0.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
522
Price
$530.23
Total Value
$276.78K
Shares Held After
208,329
% of Holdings
0.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
347
Price
$529.27
Total Value
$183.66K
Shares Held After
208,851
% of Holdings
0.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
131
Price
$527.88
Total Value
$69.15K
Shares Held After
209,198
% of Holdings
0.1%
NovaBridge Biosciences (NBP)
Cao Sean Wuxiong — Chief Bus. Development Officer
Shares
107,978
Price
$0.74
Total Value
$79.90K
Shares Held After
266,467
% of Holdings
28.8%
Tyra Biosciences, Inc. (TYRA)
Verjee Rehan — Director
Shares
972
Price
$20.58
Total Value
$20.00K
Shares Held After
972
% of Holdings
100.0%
INSMED Inc (INSM)
Brennan David R — Director
Shares
25,000
Price
$124.00
Total Value
$3.10M
Shares Held After
39,238
% of Holdings
38.9%
Pharvaris N.V. (PHVS)
Glassman Robert — Director
Shares
8,000
Price
$37.55
Total Value
$300.40K
Shares Held After
10,500
% of Holdings
43.2%
RELMADA THERAPEUTICS, INC. (RLMD)
TRAVERSA SERGIO — Director
Shares
100,000
Price
$4.18
Total Value
$418.00K
Shares Held After
1,400,000
% of Holdings
7.1%
RELMADA THERAPEUTICS, INC. (RLMD)
Shenouda Maged — Chief Financial Officer
Shares
120,200
Price
$4.20
Total Value
$504.84K
Shares Held After
920,200
% of Holdings
13.1%
Protagonist Therapeutics, Inc (PTGX)
PATEL DINESH V PH D — Director
Shares
63,548
Price
$146.18
Total Value
$9.29M
Shares Held After
522,968
% of Holdings
10.8%
Inhibrx Biosciences, Inc. (INBX)
MANHARD KIMBERLY — Director
Shares
500
Price
$115.80
Total Value
$57.90K
Shares Held After
9,000
% of Holdings
5.3%
Fortrea Holdings Inc. (FTRE)
Russell Carrie Elizabeth — Interim CAO
Shares
246
Price
$16.85
Total Value
$4.15K
Shares Held After
2,384
% of Holdings
9.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$509.00
Total Value
$101.80K
Shares Held After
324,443
% of Holdings
0.1%
Showing 151–200 of 3300 transactions (page 4 of 66)